Skip to main content
. 2020 Sep 15;109(12):3579–3589. doi: 10.1016/j.xphs.2020.09.014

Table 5.

Comparison of Wavelength at Zero Intensity, Spectra Minima and Broad Shoulder for IgG1 DS From Different Manufacturing Processes.

Description of Formulation Wavelength in nm
Zero Intensity Spectra Minima Broad Shoulder
IgG1 DS at 200 mg/mL (Control) 209.2 217.3 227.2
IgG1 Lyophilized (Control) 209.4 218.2 227.7
IgG1 Spray Freeze Dried 209.6 217.4 227.5
IgG1 Spray Dried 209.8 217.3 228.1
IgG1 from TFF 209.6 215.5 228.1